Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2008
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008151828A2 Novel microbiocides
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008104942A3 Muscarinic receptor antagonists
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008WO2008080056A3 Pyridazinones and furan-containing compounds
12/18/2008US20080312310 Compounds, Compositions and Methods
12/18/2008US20080312299 Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312161 Compounds For Stabilizing Factor VII Polypeptide Formulations
12/18/2008US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders
12/18/2008US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008CA2690567A1 New compounds
12/18/2008CA2689209A1 Piperazine compounds having herbicidal action
12/18/2008CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008CA2688237A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008CA2688208A1 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
12/18/2008CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/17/2008EP2003497A1 Inkless reimageable printing paper and method
12/17/2008EP2003488A2 Second order nonlinear optical chromophores, Polymers containing the same, and electro-optic devices therefrom
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001848A1 Piperidines and related compounds for the treatment of dementia
12/17/2008EP2001478A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP1684744A4 Pyrrolidine and piperidine derivatives as factor xa inhibitors
12/17/2008EP1443822B1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
12/17/2008EP1282609B1 Piperazinedione compounds
12/17/2008EP1222305B1 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
12/17/2008CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase
12/17/2008CN101326167A Pyridiazinone derivatives for tumour treatment
12/17/2008CN101326166A Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
12/17/2008CN101323591A 5- or 6-substited naphthoyl imines compounds and antineoplastic application
12/17/2008CN100443483C Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses
12/17/2008CN100443481C Imidazolyl-cyclic acetals
12/17/2008CN100443474C New pyridazin-3(2h)-one derivatives
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465808 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid and Na salt; 3-[5-Benzo[1,3]dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazol-3-yl]-2-(3-chloro-phenyl)-acrylic acid; 5-{(S)-2-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-pyrazol-3-yl]-1-m-tolyl-ethyl}-1H-tetrazole
12/16/2008US7465807 Process for preparing benzimidazole thiophenes
12/16/2008US7465799 Methods and compositions for selectin inhibition
12/16/2008US7465798 Methods and compositions for selectin inhibition
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008US7465747 Fluorescent label compounds
12/16/2008US7465744 Triazole compounds and the therapeutic use thereof
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/11/2008WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/11/2008WO2008150029A1 Quinolone compound and pharmaceutical composition
12/11/2008WO2008149965A1 Pyridone compound
12/11/2008WO2008149382A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
12/11/2008WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008WO2008149110A1 Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated
12/11/2008WO2008149053A1 Bicycl0 [2. 2. 1] he pt- 2-ylamine derivates and their use
12/11/2008WO2008148747A2 Pdz domain modulators
12/11/2008WO2008148302A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/11/2008WO2008110308A3 Novel herbicides
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008028032A3 Therapeutic substituted hydantoins and related compounds
12/11/2008WO2007100657A3 Inhibitors of histone deacetylase
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306121 Bisheterocycle Tandem Compounds Useful as Antiviral Agents, the Uses Thereof and the Compositions Comprising Such Compounds
12/11/2008US20080306111 Tricyclic delta- opioid modulators
12/11/2008US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
12/11/2008US20080306087 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-4-(2-nitro-phenylmethanesulfonyl)-piperazine; acylation or sulfonamidation of the piperazine ring; psychological disorders, Parkinson's, Alzheimer's, Huntington's Diseases; antidepressants, entiepileptics
12/11/2008US20080306082 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases
12/11/2008US20080306071 Substituted piperidine compounds and methods of their use
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306056 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
12/11/2008US20080306045 1-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors
12/11/2008DE112007000299T5 Verfahren zur Herstellung von aromatischer Verbindung Process for the preparation of aromatic compound
12/11/2008CA2698704A1 Novel compounds
12/11/2008CA2693552A1 Pyridone compound
12/11/2008CA2690101A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008CA2688448A1 Quinolone compound and pharmaceutical composition
12/11/2008CA2688136A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
12/10/2008EP2001064A1 Organic electroluminescence element material and organic electroluminescence element using such material
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008CN101321747A Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
12/10/2008CN101321728A Diaminoarylene compound having carbazolyl group and use thereof
12/10/2008CN100441571C Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
12/10/2008CN100441185C 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
12/09/2008US7462726 Conjugated thiophene compound comprising perfluorinated and alkylated sidechains, conductive organic thin film containing the compound, and field-effect type organic transistor employing the thin film
12/09/2008US7462723 e.g. N1-[(E)-1-(4-fluorophenyl)methylidene]-4-(1,3-thiazol-2-yl)-1H-1,2-imidazolediamine; anticarcinogenic agent; sid effect reduction
12/09/2008US7462640 e.g. 5-Chloro-3-methyl-N-[1-[2-(pyrrolidin-1-yl)ethyl-1H-indol-6-yl]-benzo[b]thiophene-2-sulfonamide; serotonin receptor modulator; anxiolytic agent, antidepressant; nervous and gastrointestinal disorders, antidiabetic agent; bipolar disorders, cognitive memory disorders, neurodegenerative disorders
12/09/2008US7462631 e.g. 4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-3-methyl-N-piperidin-1-ylthiophene-2-carboxamide; cannabinoid receptor antagonist; antiinflammatory agent; obesity, gastrointestinal disorders, inflammatory phenomena, immune system diseases, psychotic disorders, alcohol and nicotine dependence
12/09/2008US7462630 Diarylalkene derivatives and novel diarylalkane derivatives
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/04/2008WO2008147697A1 Benzimidazolone chymase inhibitors
12/04/2008WO2008147314A1 Spirocyclopropyl piperidine derivatives
12/04/2008WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity